|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/7048 | (2006.01) |
| A61P 31/04 | (2006.01) | ||
| A61P 1/12 | (2006.01) |
| (11) | Patento numeris | 3316892 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16756939.1 |
| Europos patento paraiškos padavimo data | 2016-07-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-07-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/001140 |
| Data | 2016-07-04 |
| (87) | Numeris | WO 2017/005358 |
| Data | 2017-01-12 |
| (30) | Numeris | Data | Šalis |
| 15075021 | 2015-07-03 | EP |
| (72) |
KARAS, Andreas, Johannis , NL
LONGSHAW, Christopher, Mark , NL
DELGADO-HERRERA, Leticia , NL
ZEIHER, Bernhardt, George , NL
|
| (73) |
Tillotts Pharma AG ,
Baslerstrasse 15, 4310 Rheinfelden,
CH
|
| (54) | NOVEL DOSAGE REGIMEN OF TIACUMICIN COMPOUND |
| NOVEL DOSAGE REGIMEN OF TIACUMICIN COMPOUND |